Abstract:【Abstract】 Objective To investigate the biological effects of adenovirusmediated GDF5 (AdGDF5) on extracellular matrix (ECM) expression in human degenerative disc nucleus pulposus (NP) cells, and explore a candidate gene therapy method for intervertebral disc degeneration (IDD). Methods NP cells were isolated, cultured, and then infected by the optimal multiplicity of infection (MOI) of AdGDF5 were set up as experimental group (GDF5 group), and compared with blank control group (Control group) and AdGFP control group (GFP group). The extracellular matrix expressions of NP cells were evaluated at 3, 7, 14 or 21days. The contents of sulfated glycosaminoglycan (sGAG) and hydroxyproline (Hyp) in NP cells were measured. The expression of aggrecan, typeII collagen and proteoglycan were observed respectively by immunofluorescent staining, immunohistochemical staining and SafranineO staining. The transcriptions of aggrecan and collagen II mRNA were analyzed by realtime quantitative polymerase chain reaction (Real timePCR). Results The contents of sGAG and Hyp in NP cells gradually increased following cells culture in all three groups. The GDF5 group exhibited a significantly higher sGAG/DNA than GFP and Control groups on 14 or 21 days (P<0.05), and showed a significantly greater Hyp/DNA than GFP and Control groups on 7, 14 or 21 days (P<0.05), whereas GFP group did not show a greater effect than Control group (P>0.05). The NP cells were stained for aggrecan (Immunofluorescent staining), typeII collagen (Immunohistochemical staining) and proteoglycan (SafranineO staining). The NP cells infected by GDF5 exhibited robust staining on 14 or 21 days, and weakly staining intensity either GFP or Control group. Levels of RNA transcripts for aggrecan and collagen II expression patterns were determined in NP cells using realtime PCR. Compared with GFP or Control groups, GDF5treated group had a significantly upregulated aggrecan and collagen II expression levels on 14 or 21 days point (P<0.05), whereas GFP group did not demonstrate a significant enhancement than Control group (P>0.05). Conclusion AdGDF5 could obviously upregulate aggrecan and collagen II mRNA transcription in NP cells and increase the synthesis of proteoglycan and typeII collagen. AdGDF5 could restore the extracellular matrix of degenerated NP cells and could be a potential candidate method of gene therapy for IDD.